June 2021 - DTx Pharma

DTx Pharma to Participate in the 2021 BMO BioPharma Day: Spotlight on Rare Disease and Ophthalmology

adamdtx2022-09-30T17:39:18-07:00June 16th, 2021|

San Diego – June 16, 2021 – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of [...]

DTx Pharma Appoints Jill Howe as Chief Financial Officer

adamdtx2021-06-07T06:22:17-07:00June 7th, 2021|

San Diego – June 7, 2021 – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, [...]

Biocentury | DTx: Optimizing RNA therapies for cellular uptake, biodistribution

adamdtx2021-06-02T08:28:04-07:00June 2nd, 2021|

DTx Pharma featured in BioCentury. May 11, 2021 Emerging Company Profile. Scroll down to read more.

Monthly Archives: June 2021

DTx Pharma to Participate in the 2021 BMO BioPharma Day: Spotlight on Rare Disease and Ophthalmology

DTx Pharma Appoints Jill Howe as Chief Financial Officer

Biocentury | DTx: Optimizing RNA therapies for cellular uptake, biodistribution